| Returns | 1W : 9.6% , 1M : 31.5%,1Y : 67% |
| Peers & Returns | 1W | 1M | 1Y |
| CADILA HEALTHCARE | 9.6% | 31.5% | 67% |
| SUN PHARMACEUTICAL INDUSTRIES | 1.2% | 11.4% | 36.3% |
| DR REDDYS LABORATORIES | 7.4% | 23.5% | 34.1% |
| DIVIS LABORATORIES | -0.8% | 14.8% | 61.7% |
| CIPLA | 3.3% | 25.1% | 62.3% |
| BIOCON | -1.2% | 2.6% | 12.1% |
| AUROBINDO PHARMA | 8.6% | 23.1% | 82.7% |
| LUPIN | 1.1% | 6.1% | 34.7% |
| TORRENT PHARMACEUTICALS | 0.4% | 8.8% | 11.6% |
| Ratio | Value |
|---|---|
|
P/E P/B P/S |
48.06
P/E Calculated based on EPS of 11.49
[ Mar2020 - Consolidated Results ] 5.45
P/B Calculated based on Book Value of 101.33
[ Mar2020 - Consolidated Results ] 3.93
P/S Calculated based on Revenues of 14396.7 Cr
[ TTM - Consolidated Results ] |
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
55% 37% 33% |
| Pledged Shares |
0 % |
|---|---|
| As on : Sep2020 | |
If less than 25% | Good |
| If between 25% and 50% | Neutral |
| If greater than 50% | Bad |
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE HEALTHCARE | 3.7% | 15.3% | 56.9% |
| S&P BSE MOMENTUM | 0.5% | 10.6% | 36% |
| S&P BSE ALLCAP | -0.8% | -0.3% | 59.7% |
| S&P BSE 500 | -0.9% | -0.4% | 58.8% |
| S&P BSE 250 LARGEMIDCAP | -0.9% | -0.4% | 57.2% |
| S&P BSE 200 | -1% | -0.5% | 56.9% |
| S&P BSE LARGE MIDCAP | -1% | -0.7% | 55.6% |
| S&P BSE DIVIDEND STABILITY | -1.1% | -0.6% | 48.4% |
| S&P BSE 100 LARGECAP TMC | -1.1% | -0.7% | 53.9% |
| S&P BSE LARGECAP | -1.2% | -0.9% | 53.7% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY PHARMA | 3% | 16.2% | 46.8% |
| NIFTY ALPHA LOW-VOLATILTY 30 | 0.4% | 4.3% | 39.7% |
| NIFTY NEXT 50 | -0.1% | 1.6% | 46.2% |
| NIFTY 100 EQUAL WEIGHT | -0.3% | 1.2% | 60.5% |
| NIFTY 500 | -0.9% | -0.4% | 58.3% |
| NIFTY LARGE MIDCAP 250 | -0.9% | -1.7% | 65% |
| NIFTY 200 | -1% | -0.4% | 55.9% |
| NIFTY 100 | -1.1% | -0.7% | 53.2% |
